Innovating Works

filtering by call: HORIZON-JU-GH-EDCTP3-2024-Mpox

MBOTE-SK: Tackling and investigating the South-Kivu mpox outbreak INSTITUUT VOOR TROPISCHE GENEESKUNDE processed a HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2024-Mpox With the Mpox Biology, Outcome, Transmission, and Epidemiology in South Kivu (MBOTE-SK) project, we seek emergency funding to address one of...
2024-08-01 - 2027-01-31 | financed
ODIN-MPox: Implementing wastewater and environmental surveillance for Mpox in Sub-Saharan Africa LUNDS UNIVERSITET processed a HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2024-Mpox Mpox, a re-emerging viral zoonotic disease, has recently posed significant public health challenges in sub-Saharan Africa, particularly in t...
2024-08-01 - 2026-07-31 | financed
PREGMPOX: Impact of MPXV infection on pregnancy outcome and newborn health UNIVERSITEIT ANTWERPEN processed a HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2024-Mpox Pregnant women have an increased risk of severe mpox disease, however, the underlying mechanisms remain elusive. To better understand altere...
2024-08-01 - 2027-07-31 | financed
PregInPoxVac: MATERNAL AND INFANT SAFETY AND IMMUNOGENICITY IN A PHASE 3, OPEN-LABEL, RANDOMISED, VACCINE TRIAL OF... UNIVERSITEIT ANTWERPEN processed a HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2024-Mpox Mpox can cause severe complications in vulnerable groups such as pregnant women and children, necessitating targeted public health intervent...
2024-08-01 - 2027-07-31 | financed
PREGMPOX: Impact of MPXV infection on pregnancy outcome and newborn health Pregnant women have an increased risk of severe mpox disease, however, the underlying mechanisms remain elusive. To better understand altere...
2024-07-26 - 2027-07-31 | financed
MpoxVax AFRIVAC: Expanding a prospective clinical trial examining the immune response of participants receiving Modi... The current Mpox outbreak affecting the Democratic Republic of the Congo, ongoing since 2023, has resulted in more than 19,000 causes and ov...
2024-10-03 - 2027-03-31 | financed
PregInPoxVac: MATERNAL AND INFANT SAFETY AND IMMUNOGENICITY IN A PHASE 3 OPEN LABEL RANDOMISED VACCINE TRIAL OF... Mpox can cause severe complications in vulnerable groups such as pregnant women and children, necessitating targeted public health intervent...
2024-08-26 - 2027-07-31 | financed
MPOX-PROBE: Strengthening epidemiological genomic and community surveillance of Mpox virus MPXV at the Congo... The spread of Mpox virus (MPXV) in Sub-Saharan Africa, specifically Democratic Republic of Congo (DRC) and Republic of Congo (RoC) presents...
2024-09-27 - 2026-09-30 | financed
DECIPHER-MPOX: Deciphering host genetics and viral determinants of MPOX epidemiology in the Democratic Republic of... Background: Monkeypox virus (MPV) is a member of the Poxviridae family that includes smallpox, cowpox and chickenpox viruses. Endemic to equ...
2024-08-09 - 2026-07-31 | financed
ODIN-MPox: Implementing wastewater and environmental surveillance for Mpox in Sub Saharan Africa LUNDS UNIVERSITET processed a HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2024-Mpox Mpox, a re-emerging viral zoonotic disease, has recently posed significant public health challenges in sub-Saharan Africa, particularly in t...
2024-08-07 - 2026-07-31 | financed
MBOTE-SK: Tackling and investigating the South Kivu mpox outbreak INSTITUUT VOOR TROPISCHE GENEESKUNDE processed a HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2024-Mpox With the Mpox Biology, Outcome, Transmission, and Epidemiology in South Kivu (MBOTE-SK) project, we seek emergency funding to address one of...
2024-07-29 - 2027-01-31 | financed